Bryan J. Schneider
0000-0003-4189-3805
Publication & Citation Trends
Publications
0 total
Phase II Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients with Locally Advanced Non-Small Cell Lung Cancer.
Cited by 2
Semantic Scholar
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.
Cited by 81
Semantic Scholar
A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
Cited by 16
Semantic Scholar
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma
Cited by 51
Semantic Scholar
Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I–inhibiting Antibody–Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan OA
Cited by 134
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(47)
Lung Cancer Research Studies
(36)
Cancer Immunotherapy and Biomarkers
(35)
Lung Cancer Diagnosis and Treatment
(30)
Gastric Cancer Management and Outcomes
(16)
Affiliations
Indiana University Health
Novartis (Switzerland)
University of Vienna
American Society of Clinical Oncology
Statistics Austria